Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase 3 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 689INDUSTRY 468NIH 65OTHER_GOV 14NETWORK 12INDIV 4UNKNOWN 3FED 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Breast Neoplasms 21Stomach Neoplasms 14Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Rectal Neoplasms 7Triple Negative Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Small Cell Lung Carcinoma 4Lymphoma, Extranodal NK-T-Cell 4Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Brain Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Vomiting 2Sarcoma 2Recurrence 2Nasopharyngeal Carcinoma 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2HER2-positive Breast Cancer 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Lung 1Radiation Injuries 1Platinum-resistant Recurrent Ovarian Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pain 1Ovarian Neoplasms 1

Interventions

nabiximols 1apatinib 1Sunitinib 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × Neoplasms × Clear all
NCT03199677 2017-07-02

A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer

ChineseAMS

Phase 2 Unknown
40 enrolled
Head & Neck

Neoplasms, Thyroid Neoplasms

NCT00530764 2013-06-20

SPRAY

GWPharm

Phase 2 Completed
360 enrolled 18 charts

Neoplasms, Pain

NCT01850147 2013-05-09

Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

ChineseAMS

Phase 2 Unknown
50 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡